ABEO
Abeona Therapeutics
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
ABEO Profile
Abeona Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing cell and gene therapies for life-threatening rare genetic diseases
Biological Technology
Invalid Date
12/19/2014
NASDAQ Stock Exchange
136
12-31
Common stock
6555 Carnegie Avenue, 4th Floor, Cleveland, OH 44103
--
Abeona Therapeutics, Inc., founded in Wyoming in 1974 under the name Chemex Corporation, was renamed Chemex Pharmaceuticals, Inc., in 1983. The company changed its registered address from Wyoming to Delaware on June 30, 1989. In 1996, the company merged with Access Pharmaceuticals, Inc., a private Texas company, and changed its name to Access Pharmaceuticals, Inc. The company is an emerging biopharmaceutical company dedicated to the development of a range of pharmaceutical product delivery technologies based primarily on the company's nano-polymer chemical technology and other drugs. The company currently has licenses to sell products in the United States, China and South Korea.